Changmao Biochemical Engineering Company Limited (0954.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 135.6M |
| Enterprise Value | 606.72M |
| P/E Ratio | -1.85 |
| PEG Ratio | 1.69 |
| Price/Sales Ratio | 0.22 |
| Price/Book Ratio | 0.24 |
| Enterprise/Revenue | 1.07 |
| Enterprise/EBITDA | 43.26 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.12 |
| Operating Margin | -0.09 |
AD
Management Effectiveness
| Return On Assets | -0.06 |
| Return On Equity | -0.12 |
Income Statement
| Revenue | 556.92M |
| Revenue/Share | 1.05 |
| Gross Profit | 28.57M |
| EBITDA | 13.76M |
| Net Income | -66.76M |
| Diluted EPS | -0.13 |
Balance Sheet
| Total Cash | 71.83M |
| Total Cash/Share | 0.14 |
| Total Debt | 539.3M |
| Total Debt/Equity | 1.04 |
| Current Ratio | 0.5 |
| Book Value Per Share | 0.97 |
Price History
| 52-Week Change | -10 |
| 52-Week High | 0.36 |
| 52-Week Low | 0.27 |
| Moving Average 50 Days | 0.31 |
| Moving Average 200 Days | 0.31 |
Statistics
| Average Volume | 33,666 |
| Shares Outstanding | 529.7M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
